Nautilus Biotechnology (NAUT) FY Conference June 10, 2025 02:00 PM ET Speaker0 You do, okay. Speaker1 question, I'll answer that. Speaker0 Oh, you're right. It does have that. Great. Good afternoon, everyone. I'm Matt Sykes, Life Science Tools and Diagnostics Analyst at Goldman Sachs. I have the pleasure of welcoming Anna Mari from Nautilus Biotechnologies. Thank you, Anna, for being here. Appreciate it. Maybe just starting off with big picture, can you give us kind of a brief overview of the proteomics mar ...

SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the Goldman Sachs 46th Annual Global Healthcare Conference. Nautilus’ management is scheduled to participate in a fireside chat on Tuesday, June 10, 2025, at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number 001-39434 NAUTILUS BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) FORM 10-Q Delaware 98-154172 ...

Nautilus Biotechnology (NAUT) Q1 2025 Earnings Call April 29, 2025 01:27 PM ET Speaker0 Good day, and thank you Speaker1 for standing by. Welcome to the Nautilus First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To ...

Nautilus Biotechnology (NAUT) Q1 2025 Earnings Call April 29, 2025 08:30 AM ET Company Participants Ji-Yon Yi - Vice PresidentSujal Patel - Co-Founder, CEO & DirectorParag Mallick - Co-Founder, Chief Scientist & DirectorAnna Mowry - Chief Financial OfficerElizabeth Koslosky - Global Investment Research AssociateThomas VonDerVellen - Equity Research Associate Conference Call Participants Jason Lai - Analyst Operator Good day, and thank you for standing by. Welcome to the Nautilus First Quarter twenty twenty ...

Nautilus Biotechnology (NAUT) Q1 2025 Earnings Call April 29, 2025 08:30 AM ET Company Participants Ji-Yon Yi - Vice PresidentSujal Patel - Co-Founder, CEO & DirectorParag Mallick - Co-Founder, Chief Scientist & DirectorAnna Mowry - Chief Financial OfficerElizabeth Koslosky - Global Investment Research AssociateThomas VonDerVellen - Equity Research Associate Conference Call Participants Jason Lai - Analyst Operator Good day, and thank you for standing by. Welcome to the Nautilus First Quarter twenty twenty ...

"In Q1, we saw continued development progress based on the results of internal verification and validation work we've done on our Tau proteoform assay," said Sujal Patel, CEO of Nautilus Biotechnology. "The assay's reproducibility, accuracy, dynamic range, and sample compatibility align closely with our anticipated launch specifications and with the requirements we continue to hear from potential customers and partners. We are confident that 2025 will be the year that researchers begin to apply the Nautilus ...

Exhibit 99.1 Nautilus Biotechnology Reports First Quarter 2025 Financial Results SEATTLE, WA, April 29, 2025 – Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single- molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2025. "In Q1, we saw continued development progress based on the results of internal verification and validation work we've done on our Tau proteoform assay," said Sujal Patel, CEO of Nautilus Biotechno ...

文章核心观点 公司将公布2025年第一季度财务结果并召开电话会议讨论相关情况 [1][2] 财务结果公布 - 公司将于2025年4月29日美股开盘前公布2025年第一季度财务结果 [1] 电话会议安排 - 公司管理层将在太平洋时间上午5:30/东部时间上午8:30进行网络直播电话会议，讨论财务结果、业务发展和前景 [2] - 网络直播音频可在公司网站“投资者”板块收听 [2] 公司介绍 - 公司总部位于华盛顿州西雅图，研发总部位于加利福尼亚州圣卡洛斯，是一家处于发展阶段的生命科学公司 [3] - 公司致力于创建量化和解读蛋白质组复杂性的平台技术，使命是通过普及蛋白质组获取途径，推动人类健康和医学领域的进步 [3] 联系方式 - 媒体联系邮箱为press@nautilus.bio [3] - 投资者联系邮箱为investorrelations@nautilus.bio [4]

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag Mallick - Co-Founder & Chief Scientist Anna Mowry - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Subbu Nambi - Guggenheim Securities Dan Brennan - TD Cowen Will Ortmayer - Goldman Sachs Operator Good day, and thank you for standing by. Welcome to the Nautilu ...